Tech Center 1600 • Art Units: 1677 1678 1682
This examiner grants 28% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16925923 | ENHANCED ELECTROCHEMICAL DETECTION USING NANOPARTICLES AND PRECIPITATION | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17943776 | NMASS SPECTROMETRY-BASED STRATEGY FOR CHARACTERIZING HIGH MOLECULAR WEIGHT SPECIES OF A BIOLOGIC | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 16646296 | IDENTIFICATION AND MONITORING OF ACID HYDROLYSIS PRODUCTS OF IMMUNOGLOBULIN HEAVY CHAINS | Final Rejection | Mayo Foundation for Medical Education and Research |
| 18451352 | METHOD FOR RESOLVING COMPLEX, MULTISTEP ANTIBODY INTERACTIONS | Non-Final OA | Hoffmann-La Roche Inc. |
| 16962246 | PERIODONTAL DISEASE DIAGNOSTIC METHODS, USES AND KITS | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18452029 | IMMUNOCHROMATOGRAPHIC ASSAY APPARATUS | Non-Final OA | FUJIFILM Corporation |
| 16724092 | METAL-ANTIBODY TAGGING AND PLASMA-BASED DETECTION | Final Rejection | Purdue Research Foundation |
| 17769601 | COLORIMETRIC DETECTION OF TARGET MATERIAL BASED ON HYDROGEL PARTICLE | Non-Final OA | Korea University Research and Business Foundation |
| 17333189 | Method for Diagnosing Intermittent Claudication and Chronic Limb-Threatening Ischemia | Final Rejection | McMaster University |
| 16864672 | DEVICES AND METHODS FOR SAMPLE ANALYSIS | Non-Final OA | ABBOTT LABORATORIES |
| 17438412 | INTEGRIN ALPHA V BETA 3 TARGETING PROBE FOR DIAGNOSING RETINOCHOROIDAL NEOVASCULAR DISEASES AND PREPARATION METHOD THEREFOR | Final Rejection | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 17916251 | A METHOD OF ASSESSING A FEMALE'S RISK OF HAVING PCOS AS WELL AS PRODUCTS AND USES RELATING THERETO | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 17314452 | METHODS FOR PEPTIDE MAPPING OF ADENO-ASSOCIATED VIRUS (AAV) PROTEINS | Non-Final OA | Waters Technologies Corporation |
| 17626515 | ASSAY FOR IDENTIFYING COLONY-FORMING CELLS | Non-Final OA | Miltenyi Biotec B.V. & Co. KG |
| 17263809 | METHOD FOR DETECTING BIOMARKERS | Non-Final OA | Veravas, Inc. |
| 17999729 | PREDICTING A SEPSIS CONDITION | Non-Final OA | Hermann Mascher |
| 17608076 | METHOD FOR THE DETECTION OF PROSTATE CANCER | Non-Final OA | Belgian Volition SPRL |
| 15419797 | APPARATUS AND METHOD FOR DETECTING ANALYTES IN SOLUTION | Final Rejection | Mara Nanotech New York, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy